80% of people worldwide are below cardioprotective levels of omega-3s.

Recent research supports the importance of EPA and DHA for a variety of cardiovascular outcomes, including reducing the risk of coronary heart disease, myocardial infarction and cardiac death.

Read here about an groundbreaking new meta-analysis on the topic published in Mayo Clinic Proceedings.


Read below about the many more reasons to recommend omega-3s for your patient's heart.

View all research